Skip to main content
Glama

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description goes far beyond the annotations by disclosing cascading internal lookups, graceful degradation when LEI/FIGI sources are unavailable, explicit 'unresolved' reporting, source-labeling of identifiers, and the candidate-returning behavior for ambiguous names. These are genuinely useful behavioral traits that the agent cannot infer from readOnlyHint/openWorldHint/idempotentHint alone.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but nearly every sentence adds operational value. It is front-loaded with usage examples then proceeds through supported types, edge-case behavior, and failure modes. A slight organizational simplification would make it more scannable, but the verbosity is justified given the tool's complexity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a tool with no output schema and two parameters, the description covers the full invocation contract: input formats per type, edge cases like ambiguous bonds, unresolved identifiers, source attribution, degradation behavior, and the fact that it replaces multiple manual lookups. An agent has enough information to call it correctly and interpret its results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema description coverage is 100%, the description adds substantial parameter-level meaning: it clarifies that `value` must be the entity name only, provides examples for both company and drug types, and warns against including trailing security-class words for bond issuers. This is precisely the kind of guidance that prevents invocation errors, so it earns more than the baseline 3.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses a specific verb ('resolve') and resource ('user-spoken NAME to canonical/official identifiers'), and immediately distinguishes the tool's role as the provider of IDs that other tools require. It enumerates supported entity types and what identifiers are returned for each, making its purpose unmistakable and differentiating it from sibling tools like entity_profile or compare_entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives clear usage guidance: 'Use FIRST whenever you have a name but need an ID.' It also gives example phrasings and explains when the tool intentionally returns candidates rather than asserting a single answer. However, it does not explicitly name alternative tools or state when not to use this tool, so it falls short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Several tools have genuinely unclear boundaries: ask_pipeworx and ask_pipeworx_beta are currently identical in behavior, and the polymarket_edges / polymarket_arbitrage / polymarket_kalshi_spread trio all scan for mispricings with overlapping descriptions. The rich usage notes help, but they cannot fully rescue a set where two tools literally do the same thing right now.

Naming Consistency3/5

The majority of tools use readable snake_case, but conventions are mixed: verb-first names (get_index_data, resolve_entity, validate_claim) sit alongside noun-first names (catalog_browse, index_catalog, entity_profile, bet_research), standalone verbs (remember, forget, subscribe), and adjective-led names (recent_alerts, deep_research). The pattern is predictable within clusters but not uniform across the set.

Tool Count2/5

35 tools is well above the comfortable range, and the set spans many unrelated domains—CBS Israel statistics, Pipeworx data routing, Polymarket betting, memory, subscriptions, npm dependency scanning, and AI visibility checks. Even if each tool has a purpose, the surface is bloated and poorly scoped for a server named 'Cbs Il'.

Completeness4/5

For a general data-access gateway, the set covers the major workflows: routing questions, grounded verification, deep multi-source research, entity profiles, comparisons, subscriptions, memory, and tool discovery. Minor gaps exist, such as no direct raw-record fetch without routing and no keyword search over the CBS catalog, but agents can work around these.